Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 26:16:23.
doi: 10.1186/s12950-019-0226-y. eCollection 2019.

LncRNA H19 induced by helicobacter pylori infection promotes gastric cancer cell growth via enhancing NF-κB-induced inflammation

Affiliations

LncRNA H19 induced by helicobacter pylori infection promotes gastric cancer cell growth via enhancing NF-κB-induced inflammation

Yifeng Zhang et al. J Inflamm (Lond). .

Abstract

Background: The aim of this study was to investigate the role of long non-coding RNA (lncRNA) H19 in gastric cancer (GC) with Helicobacter pylori (H. pylori).

Methods: H19 expression in peripheral blood from H. pylori+/- GC patients and healthy donors (control) as well as in GC tissues and cells were detected by qRT-PCR. Cell proliferation was evaluated by CCK-8 assay. Cell migration and invasion were evaluated by Transwell assay. The levels of pro-inflammatory cytokines were determined by ELISA. The protein levels of IκBα, p-IκBα and p65 were determined by western blotting.

Results: H19 expression was upregulated in H. pylori-infected GC tissues and cells. Furthermore, H. pylori promoted GC cell viability, migration, invasion and inflammatory response. Moreover, H19 overexpression promoted the proliferation, migration and invasion of H. pylori-infected GC cells via enhancing NF-κB-induced inflammation.

Conclusions: LncRNA H19 promotes H. pylori-induced GC cell growth via enhancing NF-κB-induced inflammation.

Keywords: Gastric cancer; H. pylori; H19; NF-κB signaling pathway.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
H19 was upregulated in HP-infected GC tissues and cells. a: H19 expression in sera from HP +/− GC patients and healthy donors (control) was detected by qRT-PCR. b: H19 expression in gastric carcinoma and adjacent normal tissues from HP +/− GC patients was detected by qRT-PCR. N = 30 for each group. c: H19 expression in SGC-7901 cells and gastric mucosa epithelial GES-1 cells following 24 h of HP infection at MOI (=0, 1, 10, 100) was detected by qRT-PCR. D: H19 expression in SGC-7901 and GES-1 cells following HP infection at MOI = 100 for 0, 6, 12, 24 h was detected by qRT-PCR. Each experiment was repeated three times. *p < 0.05 vs. control or adjacent tissue or MOI =0 or 0 h; #p < 0.05 vs. HP-
Fig. 2
Fig. 2
The effect of HP infection on GC cell behaviors. SGC-7901 cells were infected with HP at MOI = 100 for 24 h. a: Cell viability was analyzed using a CCK-8 kit. b, c: Cell migration and invasion were analyzed using transwell assays. d: The levels of pro-inflammatory cytokines were determined by ELISA. Each experiment was repeated three times. *p < 0.05 vs. control
Fig. 3
Fig. 3
The effect of H19 on cell behaviors of SGC-7901 cells infected with HP. SGC-7901 cells were transfected with H19, si-H19 and their respective controls, followed by HP infection at MOI = 100 for 24 h. a The overexpression and knockdown efficiencies of H19 were confirmed by qRT-PCR. b Cell proliferation was analyzed using a CCK-8 kit. c Cell migration and invasion were analyzed using transwell assays. Each experiment was repeated three times. *p < 0.05 vs. vector or control; #p < 0.05 vs. si-ctrl or HP+ vector;& p < 0.05 vs. HP + si-ctrl
Fig. 4
Fig. 4
H19 promoted HP-induced GC cell proliferation, migration, and invasion via NF-κB signaling pathway. a: The protein levels of phosphorylated (p)-IκBα, total (t)-IκBα, and nuclear p65 in SGC-7901 cells infected with HP at MOI = 100 for 24 h were determined by western blotting. b: The effect of H19 on HP-activated NF-κB signaling pathway was determined by western blotting. c-e: SGC-7901 cells were transfected with H19 overexpression vector and corresponding vector controls, followed by treatment with BAY11–7082 and PDTC. After which, cells were infected with HP at MOI = 100 for 24 h. c: Cell proliferation was analyzed using a CCK-8 kit. d: Cell migration and invasion were analyzed using transwell assays. e: The pro-inflammatory cytokines levels were determined by ELISA. Each experiment was repeated three times. *p < 0.05 vs. control or HP + vector; #p < 0.05 vs. HP + H19+ DMSO
Fig. 5
Fig. 5
The reversal effect of NF-κB inhibitors on H19 effect was dependent on HP infection. SGC-7901 cells were transfected with H19 overexpression vector and corresponding vector controls, followed by treatment with BAY11–7082 and PDTC. a Cell proliferation was analyzed using a CCK-8 kit. b Cell migration and invasion were analyzed using transwell assays. c The pro-inflammatory cytokines levels were determined by ELISA. Each experiment was repeated three times. *p < 0.05 vs. vector

Similar articles

Cited by

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210. - DOI - PubMed
    1. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125(3):666–673. doi: 10.1002/ijc.24290. - DOI - PubMed
    1. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–3079. doi: 10.1245/s10434-010-1362-z. - DOI - PubMed
    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107. - DOI - PubMed
    1. Yang Z, Guo X, Li G, Shi Y, Li L. Long noncoding RNAs as potential biomarkers in gastric cancer: opportunities and challenges. Cancer Lett. 2016;371(1):62–70. doi: 10.1016/j.canlet.2015.11.011. - DOI - PubMed

LinkOut - more resources